Acer therapeutics reports q3 2022 financial results and provides corporate update

Newton, mass., nov. 14, 2022 (globe newswire) -- acer therapeutics inc. (nasdaq: acer), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious, rare and life-threatening diseases with significant unmet medical needs, today reported financial results for the third quarter ended september 30, 2022 and provided an update on acer's recent corporate developments.
ACER Ratings Summary
ACER Quant Ranking